Viral determinants of HIV-1 sufficient to extend tropism to macrophages are distinct from the determinants that control the cytopathic phenotype in HL-60 cells

AIDS

Volumn 11, Issue 14, 1997, Pages 1681-1688

  DiFronzo, Nancy L ^c   Pise Masison, Cynthia A ^b   Fernandez Larsson, Roberto ^a   Holland, Christie A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Ctr Virol Immunol Infect D ^*

Author keywords

Cytopathicity; HIV; HL 60 cells; Tropism

Indexed keywords

ANTIGEN P24; GLYCOPROTEIN; VIRUS PROTEIN;

ADAPTATION; AMINO ACID SUBSTITUTION; ARTICLE; CELL CULTURE; CELL STRAIN HL 60; CELL VIABILITY; CHIMERA; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENVELOPE GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS REPLICATION;

BINDING SITES; CYTOPATHOGENIC EFFECT, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HL-60 CELLS; HUMANS; MACROPHAGES; PHENOTYPE; REASSORTANT VIRUSES;

EID: 0030831663     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199714000-00004     Document Type: Article

References (46)

1. Åsjö B, Morfeldt-Manson L, Albert J, et al.: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986, ii:660-662.
2. Fenyö EM, Albert J, Åsjö B: Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 1989, 3 (suppl 1):S5-S12.
3. Ma X, Sakai K, Sinangil F, Golub E, Volsky DJ: Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells efficient virus entry followed by delayed expression of its DNA and protein. Virology 1990, 176:184-194.
4. Sakai K, Dewhurst S, Ma X, Volsky DJ: Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol 1988, 62:4078-4085.
5. Stamatatos L, Cheng-Mayer C: Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J Virol 1993, 67:5635 5639.
6. York-Higgins D, Cheng-Mayer C, Bauer D, Levy JA, Dina D: Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J Virol 1990, 64:4016-4020.
7. Fenyo EM, Morfeldt-Manson L, Chiodi F, et al.: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1998, 62:4414-4419.
8. Cheng-Mayer C, Seto D, Tateno M, Levy JA: Biological features of HIV-1 that correlate with virulence in the host. Science 1988, 240:80 82.
9. Schuitemaker H, Koot M, Kootstra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992, 66:1354-1360.
10. Tersmette M, Gruters RA, DeWolf F, et al.: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989, 63:2118 2125.
11. Adachi A, Gendelman HE, Koenig S, et al.: Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291.
12. Pise CA, Newburger PE, Holland CA: Human immunodeficiency virus type 1-infected HL-60 cells are capable of both monocytic and granulocytic differentiation. J Gen Virol 1992, 73:3257-3261.
13. Pise-Masison CA, Holland CA: Restricted replication of the HIV-1 T-lymphotropic isolate NL4-3 in HL-60 cells. Virology 1995, 206:641 645.
14. Wahl LM, Katona IM, Wilder RL, et al.: Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE) in characterization of B-lymphocyte, T-lymphocyte, and monocyte enriched fractions by flow cytometric analysis. Cell Immunol 1984, 85:373-383.
15. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, Gallo RC: Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983, 129:51 64.
16. Gartner S, Markovitz P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215 219.
17. Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967, 26:365 369.
18. Cann AJ, Churcher MJ, Boyd M, et al.: The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol 1992, 66:305 309.
19. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253:71 74.
20. Boyd ML, Simpson GR, Cann AJ, Johnson MA, Weiss RA: A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol 1993, 67:3649-3652.
21. Fujita K, Silver J, Peden K: Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1. J Virol 1992, 66:4445 4451.
22. Kim LM, Kolson DL, Balliet JW, Srinivasan A, Collman RG: V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. J Virol 1995, 69:1755 1761.
23. Koito A, Harrowe G, Levy JA, Cheng-Mayer C: Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J Virol 1994, 68:2253-2259.
24. Schnittman SM, Psallidopoulos MC, Lane HC, et al.: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989, 245:305 308.
25. Willey RL, Theodore TS, Martin MA: Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J Virol 1994, 68:4409 4419.
26. Westervelt P, Gendelman HF, Ratner L: Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci USA 1991, 88:3097 3101.
27. Westervelt P, Henkel T, Trowbridge DB, et al.: Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency type 1 determinants. J Virol 1992, 66:3925 3931.
28. Chesebro B. Wehrly K, Nishio J, Perryman S: Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992, 66:6547 6554.
29. Chang J, Shan E, Nait L, Cunningham A: The magnitude of HIV replication in monocytes and macrophages is influenced by environmental conditions, viral strain, and host cells. J Leukoc Biol 1994, 56:230 235.
30. Takeuchi Y, Akutsu M, Murayama K, Shimizu N, Hoshino H: Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol 1991, 65:1710-1718.
31. Shioda T, Levy JA, Cheng-Mayer C: Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991, 349:167 169.
32. Westervelt P, Trowbridge DB, Epstein LG, et al.: Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol 1992, 66:2577 2582.
33. O'Brien WA, Koyanagi Y, Namazie A, et al.: HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990, 348:69 73.
34. Cheng-Mayer C, Shioda T, Levy JA: Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by a very few amino acid changes in tat and gp120. J Virol 1991, 65:6931 6941.
35. Malykh A, Reitz MS, Louie A, Hall L, Lori F: Multiple determinants of growth of human immunodeficiency virus type 1 in monocyte-macrophages. Virology 1995, 206:646 650.
36. Loohey K, Wehrly K, Nishio J, Perryman S, Chesebro B: Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 1995, 213:70 79.
37. Miller MD, Warmerdam MI, Gaston I, Greene WC, Feinberg MB: The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994, 179:101 113.
38. Balliet JW, Kolson DL, Liger G, et al.: Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 1994, 200:623 631.
39. Stevenson M, Gendelman HE: Cellular and viral determinants that regulate HIV-1 infection in macrophages. J Leukoc Biol 1994, 56:278 288.
40. Broder CC, Berger EA: Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4 T-cell lines vs. primary macrophages. Proc Natl Acad Sci USA 1995, 92:9004 9008.
41. Alkhatib G, Broder CC, Berger EA: Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J Virol 1996, 70:5487 5494.
42. Berson JE, Long D, Doranz BJ, Rucker J, Jiriknik LR, Doms RW: A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996, 70: 6288 6295.
43. Choe H, Larzan M, Sun Y, et al.: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85: 1135-1148.
44. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149 1158.
45. Feng Y, Broder CC , Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872 877.
46. Collman R, Balliet JW, Gregory SA, et al.: An infectious molecular clone of an unusual macrophage-tropic and high cytopathic strain of human immunodeficiency virus type 1. J Virol 1992, 66:7517 7521.